As of 2025-09-19, the Intrinsic Value of Encompass Health Corp (EHC) is 134.87 USD. This EHC valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 125.33 USD, the upside of Encompass Health Corp is 7.60%.
The range of the Intrinsic Value is 92.44 - 236.32 USD
Based on its market price of 125.33 USD and our intrinsic valuation, Encompass Health Corp (EHC) is undervalued by 7.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 92.44 - 236.32 | 134.87 | 7.6% |
| DCF (Growth 10y) | 123.92 - 291.23 | 173.58 | 38.5% |
| DCF (EBITDA 5y) | 95.27 - 158.38 | 120.88 | -3.5% |
| DCF (EBITDA 10y) | 121.28 - 196.73 | 151.76 | 21.1% |
| Fair Value | 51.24 - 51.24 | 51.24 | -59.12% |
| P/E | 97.57 - 137.21 | 115.98 | -7.5% |
| EV/EBITDA | 61.73 - 151.60 | 90.98 | -27.4% |
| EPV | 102.92 - 136.43 | 119.68 | -4.5% |
| DDM - Stable | 49.53 - 143.29 | 96.41 | -23.1% |
| DDM - Multi | 79.74 - 177.22 | 109.76 | -12.4% |
| Market Cap (mil) | 12,623.24 |
| Beta | 0.67 |
| Outstanding shares (mil) | 100.72 |
| Enterprise Value (mil) | 14,983.64 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.30% |
| Cost of Debt | 5.13% |
| WACC | 7.60% |